Institutional Review Board, Hospital for Special Surgery
October 05, 2007
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
Gina Aharonoff, MPH
Michael M. Alexiades, MD
Answorth A. Allen, MD
David W. Altchek, MD
Katie Belleisle
Friedrich Boettner, MD
Mathias P. Bostrom, MD
Robert L. Buly, MD
Nadia Camille
Frank A. Cordasco, MD
Charles N. Cornell, MD
Edward V. Craig, MD, MPH
Aileen Davis, MD
Huong Do, MS
Rhonda El-Sheik
Stephen Fealy, MD
Mark P. Figgie, MD
Daniel Fischer, BA
Hassan Ghomrawi, PhD, MPH
Steven R. Goldring, MD
Alejandro Gonzalez Della Valle, MD
Patrick Grimm, BA
Jason Guardado
Steven B. Haas, MD
Tamara Hagoel, BA
Gillian Hawker, MD
Jonathan Kassak
Bryan T. Kelly, MD
Adrita Khan, BA
Stephen Lyman, PhD
John D. MacGillivray, MD
C. Ronald MacKenzie, MD
Lisa A. Mandl, MD, MPH
Robert G. Marx, MD, MSc
David J. Mayman, MD
Michael J. Maynard, MD
Madhu Mazumdar, PhD, MA, MS
Alvin Mushlin, MD, ScM
Douglas E. Padgett, MD
Michael L. Parks, MD
Andrew D. Pearle, MD
Chitranjan S. Ranawat, MD
Amar S. Ranawat, MD
Renee Razzano, MA
Laura Robbins, DSW, CSW, MSW
Howard Anthony Rose, MD
John Rutledge, MS
Eduardo A. Salvati, MD
Justine Shum, BA
Edwin P. Su, MD
Russell F. Warren, MD
Geoffrey H. Westrich, MD
Thomas L. Wickiewicz, MD
Riley J. Williams III
Phillip D. Wilson Jr., MD
Russell E. Windsor, MD, PC
We will enroll all TKA patients who undergo surgery at HSS and consent to be in the study. We estimate this to be approximately 2600 patients a year, based on 2006 data. (2575 TKA were performed at HSS in 2006). Patients will receive follow-up questionnaires at one year, two years, and five years after their surgery.
Patients 18 years or older undergoing total knee arthroplasty at HSS
Principal Investigator
Thomas Sculco, MD
212.606.2478
Research Coordinator
Carolyn Thai
212.774.2754